Cannabinoid hopeful FSD taps rival’s veteran executive as CEO by Beth Snyder Bulik Monday, November 26, 2018 FSD Pharma taps competing prescription CBD company GW Pharma’s former top marketing executive to serve as its new CEO.
GW Pharma looks to dispel cannabis stigma with Epidiolex launch by Beth Snyder Bulik Friday, October 5, 2018 GW Pharmaceutical is looking to assure doctors that epilepsy treatment Epidiolex is vastly different from off-the-shelf artisan oils at cannabis shops.
